ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Internal Medicine

Top Internal Medicine Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HAO HUANG M.D.

Internal Medicine

77,745

$4.15M

1350
1175 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

RICHARD RUGGIERI M.D.

Internal Medicine

34,402

$1.78M

1113
901 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

SHAHZAD KHURSHID M.D.

Internal Medicine

32,309

$1.75M

643
566 are 65+

18%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $51

AVANISH MEHTA M.D.

Internal Medicine

27,797

$1.56M

452
387 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

RALPH SANTORO M.D.

Internal Medicine

29,193

$1.51M

693
610 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

ANTHONY LOMBARDI MD

Internal Medicine

27,497

$1.5M

768
637 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

AHMAD AL-RAQQAD M.D.

Internal Medicine

22,682

$1.11M

551
484 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

GREGORY ALLEN D.O.

Internal Medicine

18,922

$1.05M

484
330 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

AMY GOLDFARB MD

Internal Medicine

6,844

$1.04M

236
163 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$151
Average prescription price

Avg: $51

HUGO YAMADA MD

Internal Medicine

16,238

$1.03M

593
495 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $51

JEFFREY DROGIN MD

Internal Medicine

13,818

$1M

651
614 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $51

CHRISTOPHER SUPERCZYNSKI M.D.

Internal Medicine

21,901

$981K

1024
858 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $51

EDWARD GAUTHIER M.D.

Internal Medicine

19,364

$945K

334
313 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

NICHOLAS TURILLI D.O.

Internal Medicine

16,104

$905K

631
572 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

FRANK MAGGIACOMO D.O.

Internal Medicine

17,678

$894K

760
578 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $51

PATRICIA CHACE MD

Internal Medicine

15,405

$892K

372
339 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $51

BASSAM KHABBAZ MD

Internal Medicine

15,590

$888K

301
275 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $51

WILLIAM BELIVEAU MD

Internal Medicine

17,678

$867K

675
600 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $51

DAVID DICECCO M.D.

Internal Medicine

15,074

$795K

432
393 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $51

OLGA TVERSKAYA M.D.

Internal Medicine

14,018

$789K

457
364 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

RINCHEN-TZO EMGUSHOV MD

Internal Medicine

5,684

$787K

228
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 22%

$138
Average prescription price

Avg: $51

LEONARD MANNARELLI D.O.

Internal Medicine

14,299

$784K

407
240 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

20%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $51

JASON BOUDJOUK M.D.

Internal Medicine

14,931

$780K

385
339 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

17%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $51

SAPNA CHOWDHRY MD

Internal Medicine

5,656

$770K

194
57 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

21%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$136
Average prescription price

Avg: $51

GREIGSTONE YEARWOOD M.D.

Internal Medicine

13,567

$762K

488
369 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank